HAWK Biosystems is redefining how we see biology by focusing on the true drivers of cellular behavior: the interactions between proteins.
Every biological decision is governed by these molecular conversations, whether observing immune response or tumor growth. This field of study, known as interactomics, examines how proteins communicate, signal, and shape life itself. HAWK Biosystems is advancing this science by making protein interactions measurable in their native biological context.
Their technology platform translates this complexity into actionable data. The Violet 3.0 system and QF-Pro® reagents work together to enable quantitative FLIM-FRET analysis, and map protein interactions and activation states directly in FFPE tissues and live cells. This reveals how proteins function within their natural environment, ultimately connecting molecular mechanisms to clinical outcomes and therapeutic response.
What sets HAWK apart is their ability to bridge discovery and application. They combine advanced fluorescence lifetime imaging with intuitive analysis workflows, and make functional biology measurable for both researchers and clinicians. The result is clearer biological insights, more predictive biomarkers, and stronger translational pathways.
This mission aligns perfectly with our commitment to advancing reproducible, high-impact science. HAWK Biosystems exemplifies the innovation and rigor that define our partnerships and brings forward tools that transform how we understand biology.
